Testing effectiveness (Phase 2)Study completedNCT00002185
What this trial is testing
A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3
Who this might be right for
Sarcoma, KaposiHIV Infections
Agouron Pharmaceuticals 20